Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Naton Technology Group is a leading Chinese medical device manufacturer specializing in innovative orthopedic solutions. Its portfolio includes orthopedic surgical robots, biodegradable implants, trauma care products for various body parts, spine solutions, joint replacements, and advanced rehabilitation exoskeletons. In August 2024, its independently developed orthopedic surgical navigation system received Class III registration from the National Medical Products Administration (NMPA), enabling minimally invasive spinal and trauma surgeries with enhanced precision. The group operates multiple R&D centers globally and has filed over 1,600 patents. In 2023 it reported revenue of $640 million USD
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Naton Technology Group.